Category: Testing & Diagnostics

Testing & Diagnostics

Latest

ArchiMed to Acquire Natus Medical Inc

Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems, announced that it has entered into a definitive agreement to be acquired by an affiliate of ArchiMed (“ArchiMed”), an investment firm focused exclusively on the healthcare industry for approximately $1.2 billion.

Testing & Diagnostics

Latest

Inventis Releases Wireless Probes for Trumpet

According to Inventis, this now makes its wireless probes “the lightest in the market at 50 g/0.11 lb.” Trumpet’s wireless probes are designed to improve patient’s comfort and give complete freedom when performing in-situ measurements.

Testing & Diagnostics

Latest

Comparing MPOs from Six Different Hearing Aid Manufacturers: Headroom Considerations

Using 2-cc coupler measures, MPO values for different programmed settings were compared for the premier hearing aid products from six major manufacturers. Large differences were observed, and these differences were not directly associated with the product’s OSPL90. In general, at least for the sample audiogram used, it appears that the MPO is limited by the gain setting and the aggressiveness of the wide dynamic range compression (WDRC), often restricting useable headroom.

Maico Diagnostics to Hold Free Webinar on Newborn Hearing Screening

The webinar will help inspire you to look at the hearing screening process in a positive light by providing information about how important the screening is to the future of a child with hearing loss; explain the methods used to perform the screening so you have a good understanding of the techniques you are using; and give practical recommendations for obtaining high-quality hearing screening results in the shortest possible time.

Read More

An Interview with Michael Valente, PhD: Considerations after 45 Years in Audiology

On July 31st, Michael Valente will retire after 45 years in audiology and 34 years at Washington University. In this article, Douglas Beck conducts an “exit interview” with one of our most distinguished clinician-researchers about his journey in the profession, the Best Practices documents which he spearheaded, OTC devices, and the future of hearing healthcare.

Read More

Study Shows How Tests of Hearing Can Reveal HIV’s Effects on the Brain

When comparing the FFR results of 68 HIV-positive adults to 59 HIV-negative adults, the investigators found that the auditory-neurophysiological responses to certain speech cues were disrupted in HIV-positive adults, even though they performed normally on hearing tests—confirming that these hearing difficulties are grounded in the central nervous system.

Read More
Loading